Literature DB >> 18064561

Too old for IVF: are we discriminating against older women?

Norbert Gleicher1, Andrea Weghofer, David Barad.   

Abstract

In vitro fertilization (IVF) in women of advanced age (>42 years) represents only 5%, a comparatively minute part, of the national IVF experience in the United States (US). In view of evolving population dynamics, it, however, also represents proportionally a rather quickly expanding patient need. Because of access restrictions at many IVF programs, this market does not live up to its potential. As best demonstrated by the 2004 US National Summary and Fertility Clinic Report, which for the first time reported pregnancies and births above age 45 year, IVF in women of advanced reproductive age represents a cutting edge area of interest for improving current IVF outcomes. Access to IVF should, therefore, not be withheld based on female age and/or baseline FSH levels. Instead, a definition of acceptable minimal pregnancy and life birth rates could be used to define the limits of offered access to IVF, independent of age and/or baseline FSH levels.

Entities:  

Mesh:

Year:  2007        PMID: 18064561      PMCID: PMC3454997          DOI: 10.1007/s10815-007-9182-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  26 in total

1.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

Authors:  I A J van Rooij; F J M Broekmans; E R te Velde; B C J M Fauser; L F J M M Bancsi; F H de Jong; A P N Themmen
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

Review 2.  Aging and infertility in women: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

3.  Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes.

Authors:  Steven D Spandorfer; Kristin Bendikson; Kate Dragisic; Glenn Schattman; Owen K Davis; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2007-01       Impact factor: 7.329

4.  The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

Authors:  A H Watt; A T Legedza; E S Ginsburg; R L Barbieri; R N Clarke; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

5.  Cumulative delivery rates after ICSI in women aged >37 years.

Authors:  Kaan Osmanagaoglu; Herman Tournaye; Efstratios Kolibianakis; Michel Camus; Andre Van Steirteghem; Paul Devroey
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

6.  Follicle dynamics during ovarian ageing.

Authors:  M J Faddy
Journal:  Mol Cell Endocrinol       Date:  2000-05-25       Impact factor: 4.102

7.  Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study.

Authors:  Andrea Weghofer; David Barad; Jianming Li; Norbert Gleicher
Journal:  Fertil Steril       Date:  2007-02-12       Impact factor: 7.329

8.  "Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization.

Authors:  Norbert Gleicher; David Barad
Journal:  Fertil Steril       Date:  2006-10-30       Impact factor: 7.329

9.  Assisted reproductive technology surveillance - United States, 2004.

Authors:  Victoria Clay Wright; Jeani Chang; Gary Jeng; Michael Chen; Maurizio Macaluso
Journal:  MMWR Surveill Summ       Date:  2007-06-08

10.  Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization.

Authors:  Chih Chi Chuang; Chin-Der Chen; Kuang-Han Chao; Shee-Uan Chen; Hong-Nerng Ho; Yu-Shih Yang
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

View more
  8 in total

1.  Getting Older Women Pregnant: Contemporary Thoughts.

Authors:  Gautam N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2015-11-13

Review 2.  Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies.

Authors:  Hideki Igarashi; Toshifumi Takahashi; Satoru Nagase
Journal:  Reprod Med Biol       Date:  2015-05-09

3.  A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve.

Authors:  Fethiye Sinem Karipcin; Amjad Hossain; John Y Phelps
Journal:  J Assist Reprod Genet       Date:  2011-09-13       Impact factor: 3.412

4.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

Review 5.  Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).

Authors:  Norbert Gleicher; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-05-17       Impact factor: 5.211

6.  Time as an outcome measure in fertility-related clinical studies: long-awaited.

Authors:  Sesh K Sunkara; Wenjing Zheng; Thomas D'Hooghe; Salvatore Longobardi; Jacky Boivin
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

7.  Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.

Authors:  Norbert Gleicher; Eddy Ryan; Andrea Weghofer; Sonia Blanco-Mejia; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2009-10-07       Impact factor: 5.211

8.  The "graying" of infertility services: an impending revolution nobody is ready for.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2014-07-09       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.